Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists
JAMA
September 24, 2025
Matthew J. Klebanoff, Pengxiang Li, Judith A. Long, Jalpa A. Doshi
Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis
Neurology Clinical Practice
September 16, 2025
Pengxiang Li, John K Lin, Matthew J Klebanoff, Riya Palkar, Salim Chahin, Jalpa A Doshi
Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate Cancers
Journal of Clinical Oncology
August 27, 2025
John K Lin, Jiangong Niu, Sharon H Giordano, Pengxiang Li, Rebecca A Snyder, Kaiping Liao, Meng Li, Ana Aparicio, William Chapin, Jianjun Zhang, Jenny Xiang, Nirosha Perera, Debanjan Pain, Carmen E Guerra, Jalpa A Doshi
Inflation Reduction Act Provisions and Medicare Part D Out-of-Pocket Costs for Specialty Drugs
JAMA Health Forum
May 16, 2025
Jalpa A Doshi, Pengxiang Li, Matthew J Klebanoff, John K Lin
Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan
JCO Oncology Practice
April 25, 2025
Jalpa A Doshi, Pengxiang Li, Shravan Asthana, John K Lin
Opioid Cap Laws and Opioid Prescriptions After Total Joint Replacements in Older Adults
JAMA Network Open
April 9, 2025
Caroline P Thirukumaran, Derek T Schloemann, Jalpa A Doshi, Kevin A Fiscella, Benjamin F Ricciardi, Meredith B Rosenthal
Real-World Effectiveness of Long-Acting Injectable and Oral Antipsychotic Agents in US Medicare Patients with Schizophrenia
Advances in Therapy
January 15, 2025
Pengxiang Li, Zhi Geng, Carmela Benson, Charmi Patel, Jalpa A Doshi
County-Level Factors Associated with Reversal of Insurer-Approved HIV Pre-Exposure Prophylaxis Prescriptions in the United States, 2018
AIDS and Behavior
December 30, 2024
Rahel Dawit, William C. Goedel, Hsien-Yen Chang, Amy S. Nunn, Philip A. Chan, Jalpa A. Doshi & Lorraine T. Dean
Real-World Treatment Patterns After Discontinuation of Venetoclax or BTKis in the Frontline Setting Among Older Adults With Chronic Lymphocytic Leukemia
JCO Oncology Practice
December 20, 2024
Scott F Huntington, Joanna M Rhodes, Beenish S Manzoor, Dureshahwar Jawaid, Justin T Puckett, Nnadozie Emechebe, Arliene Ravelo, Sachin Kamal-Bahl, Steven E Marx, Jalpa A Doshi
Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices
Forum for Health Economics and Policy
November 8, 2024
Jason Shafrin, Jaehong Kim, Joshua T Cohen, Louis P Garrison, Dana A Goldman, Jalpa A Doshi, Joshua Krieger, Darius N Lakdawalla, Peter J Neumann, Charles E Phelps, Melanie D Whittington, Richard Willke
Real-Time Prescription Benefit Tool Adoption Among US Hospitals
JAMA Health Forum
October 4, 2024
Matthew J Klebanoff, Pengxiang Li, Paula Chatterjee, Jalpa A Doshi
Clinician Specialty and HIV PrEP Prescription Reversals and Abandonments
JAMA Network
August 19, 2024
Shivani Bakre, Hsien-Yen Chang, Jalpa A Doshi, William C Goedel, Parya Saberi, Philip A Chan, Amy Nunn, Lorraine T Dean
Real-world comparison of health care costs of venetoclax-obinutuzumab vs Bruton’s tyrosine kinase inhibitor use among US Medicare beneficiaries with chronic lymphocytic leukemia in the frontline setting
JMCP
July 24, 2024
Scott F Huntington, Beenish S Manzoor, Dureshahwar Jawaid, Justin T Puckett, Nnadozie Emechebe, Arliene Ravelo, Sachin Kamal-Bahl, Jalpa A Doshi
Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans
JAMA Network
June 6, 2024
Matthew J Klebanoff, Pengxiang Li, John K Lin, Jalpa A Doshi
Real-World Treatment Patterns, Survival, and Economic Burden Among Elderly MCL Patients Previously Treated With cBTKis
Clinical Lymphoma, Myeloma & Leukemia
June 3, 2024
Patrick Squires, Justin Puckett, Katherine Elizabeth Ryland, Sachin Kamal-Bahl, Monika Raut, Jalpa Doshi, Scott F Huntington
Health Care Resource Utilization and Costs Associated With Diagnosed Medication Overuse Headache and Potential Acute Medication Overuse in Individuals With Migraine
Cephalalgia
February 27, 2024
Anand R. Shewale, Jennifer A. Brandenburg, Kate Burslem, Richard B. Lipton, Jalpa A. Doshi